Executive Vice President, Public Affairs and Investor Relations
Susan Hubbard has served as Executive Vice President of Public Affairs and Investor Relations since December 2016. Prior to joining Exelixis in a full-time capacity, Ms. Hubbard served as an independent public affairs and investor relations consultant to the biopharmaceutical industry. From 2014, she was instrumental in developing Exelixis’ communications strategy around the late-stage clinical development, approval and commercial launch of CABOMETYX, as well as several major milestones for the company’s partnered programs. Previously, Ms. Hubbard spent over two decades at Gilead Sciences where she occupied a variety of roles of increasing responsibility, concluding her tenure as Vice President of Investor Relations. Ms. Hubbard received her undergraduate degree from the University of California, Los Angeles.